Sentinel 3.0_2026 Updated Market Research

The U.S. Food and Drug Administration (FDA) issues this Noitce as a means of conducting market research to inform acquisition planning in accordance with the Federal Acquisition Regulation (FAR) Parts 7 and 10. This notice is not a Request for Proposal (RFP), Request for Quotation (RFQ), or Invitation for Bid (IFB), and no award will result from this announcement. As part of its market research, the FDA previously issued Notice FDARFI5302025. The operational framework described in that notice has since been revised. The FDA now anticipates supporting its Sentinel 3.0 programmatic requirements with the following contract structure: Contract 1: Sentinel 3.0 Data Partners (Tiers 16, previously Tiers 15) providing access to multiple types of healthcare data. The FDA is considering a Data Broke